These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28412330)

  • 1. Re: Cambareri et al.: Do Overweight and Obese Pediatric Stone Formers Have Differences in Metabolic Abnormalities Compared With Normal-weight Stone Formers? (Urology 2017;101:26-30).
    Mahakkanukrauh P; Sinthubua A; Das S
    Urology; 2017 Jul; 105():210. PubMed ID: 28412330
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Do Overweight and Obese Pediatric Stone Formers Have Differences in Metabolic Abnormalities Compared with Normal-Weight Stone Formers?
    Assimos DG
    J Urol; 2017 Feb; 197(2):518. PubMed ID: 28093187
    [No Abstract]   [Full Text] [Related]  

  • 3. Do Overweight and Obese Pediatric Stone Formers Have Differences in Metabolic Abnormalities Compared With Normal-weight Stone Formers?
    Cambareri GM; Giel DW; Bayne AP; Corbett S; Schurtz E; Kovacevic L; Sukhu T; Yap M; Chiang G
    Urology; 2017 Mar; 101():26-30. PubMed ID: 27641936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and urolithiasis: evidence of regional influences.
    Trinchieri A; Croppi E; Montanari E
    Urolithiasis; 2017 Jun; 45(3):271-278. PubMed ID: 27488444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers.
    Negri AL; Spivacow FR; Del Valle EE; Forrester M; Rosende G; Pinduli I
    Urol Res; 2008 Dec; 36(6):303-7. PubMed ID: 18985334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: The Ability of a Limited Metabolic Assessment to Identify Pediatric Stone Formers with Metabolic Abnormalities.
    Assimos DG
    J Urol; 2019 Feb; 201(2):223. PubMed ID: 30634331
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: The Ability of a Limited Metabolic Assessment to Identify Pediatric Stone Formers with Metabolic Abnormalities.
    Canning DA
    J Urol; 2020 Dec; 204(6):1369. PubMed ID: 32960724
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A; Esen T; Ziylan O; Erol B; Armagan A; Ander H; Akinci M
    Urol Int; 2003; 70(4):273-7. PubMed ID: 12740490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Bevill et al.: The Modern Metabolic Stone Evaluation in Children (Urology 2017;101:15-20).
    Schreuder MF; van de Kar NC
    Urology; 2017 Apr; 102():267-268. PubMed ID: 28069331
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Can obese stone formers follow dietary recommendations?
    Assimos D
    J Urol; 2014 Apr; 191(4):994. PubMed ID: 24703126
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of body size on urinary stone composition in men and women.
    Daudon M; Lacour B; Jungers P
    Urol Res; 2006 Jun; 34(3):193-9. PubMed ID: 16474948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.
    Lee SC; Kim YJ; Kim TH; Yun SJ; Lee NK; Kim WJ
    J Urol; 2008 Feb; 179(2):570-4. PubMed ID: 18078957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
    Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
    Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights on the pathology of kidney stone formation.
    Evan AP; Coe FL; Lingeman JE; Worcester E
    Urol Res; 2005 Nov; 33(5):383-9. PubMed ID: 16078085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function in patients with nephrolithiasis.
    Worcester EM; Parks JH; Evan AP; Coe FL
    J Urol; 2006 Aug; 176(2):600-3; discussion 603. PubMed ID: 16813897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease risks of childhood obesity in China.
    Li YP; Yang XG; Zhai FY; Piao JH; Zhao WH; Zhang J; Ma GS
    Biomed Environ Sci; 2005 Dec; 18(6):401-10. PubMed ID: 16544522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of overweight and obesity in calcium oxalate stone formation.
    Siener R; Glatz S; Nicolay C; Hesse A
    Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.